Tirzepatide
100% Online — No Office Visit Required
Tirzepatide is a dual GLP-1 and GIP receptor agonist — the active ingredient in Mounjaro and Zepbound — that has demonstrated the highest average weight loss of any medication in clinical trials to date.
What Is Tirzepatide?
Tirzepatide activates both GLP-1 and GIP receptors — a dual mechanism that produces more pronounced effects on appetite, blood sugar, and weight than single GLP-1 agonists like semaglutide. It is the active ingredient in Mounjaro (T2D) and Zepbound (obesity).
What It May Help With
Tirzepatide is used for:
- Chronic obesity management
- Type 2 diabetes management
- Cardiovascular risk reduction in eligible patients
Who May Be a Candidate
Same eligibility criteria as other GLP-1 medications. Provider evaluation required.
How OakMD Works
OakMD is a telemedicine platform connecting eligible adults with licensed providers. If you're interested in Tirzepatide, the process begins with a brief online intake form. A licensed provider will review your health history, symptoms, and goals — and determine if treatment is appropriate for you.
If you are a candidate, your provider will create a personalized treatment plan and guide you through next steps. There are no in-person visits required.
Common Questions
Is tirzepatide better than semaglutide?
In clinical trials, tirzepatide has shown higher average weight loss. But 'better' is individual — response, tolerability, and cost all matter. Your provider can help determine which is more appropriate for you.
Ready to Get Started?
Complete a brief online intake. A licensed provider will review your information and determine if treatment is appropriate for you.
Medical Disclaimer: The information on this page is provided for educational purposes only and does not constitute medical advice. OakMD is a telemedicine platform. All treatments are prescription-based, subject to provider review, and may not be appropriate for all individuals. A licensed provider will evaluate your medical history and determine eligibility. Consult a qualified healthcare professional before starting any new treatment.